XML 28 R3.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 265,453 $ 104,641
Marketable securities 1,009 2,543
Due from related parties 2,019 1,890
Prepaid expenses and other current assets (including amounts with related parties) 25,603 31,503
Total current assets 294,084 140,577
Marketable securities, noncurrent 891 840
Property, plant and equipment, net 146,082 143,659
Intangible assets, net 17,093 20,003
Convertible note receivable 6,879 6,629
Operating lease right-of-use assets, net (including amounts with related parties) 36,543 45,788
Other assets (including amounts with related parties) 2,880 4,860
Total assets 504,452 362,356
Current liabilities:    
Accrued expenses and other liabilities 42,708 41,825
Related-party promissory notes, net of discounts and deferred issuance costs (Note 10) 0 431,901
Operating lease liabilities (including amounts with related parties) 5,244 2,650
Total current liabilities 58,283 500,861
Related-party nonconvertible note, net of discount (Note 10) 104,586 0
Related-party convertible notes and accrued interest, net of discount (Note 10) 576,951 241,271
Revenue interest liability (Note 9) 155,415 0
Derivative liabilities (Note 9 and Note 10) 35,333 0
Operating lease liabilities, less current portion (including amounts with related parties) 39,942 47,951
Warrant liabilities 118,770 21,636
Other liabilities 1,109 457
Total liabilities 1,090,389 812,176
Commitments and contingencies (Note 7)
Stockholders’ deficit:    
Common stock, $0.0001 par value; 1,350,000,000 and 900,000,000 shares authorized as of December 31, 2023 and 2022, respectively; 670,867,344 and 421,569,115 shares issued and outstanding as of December 31, 2023 and 2022, respectively; excluding 163,800 treasury stock shares outstanding as of December 31, 2023 and 2022 67 42
Additional paid-in capital 2,374,620 1,930,936
Accumulated deficit (2,961,684) (2,378,488)
Accumulated other comprehensive income 10 183
Total ImmunityBio stockholders’ deficit (586,987) (447,327)
Noncontrolling interests 1,050 (2,493)
Total stockholders’ deficit (585,937) (449,820)
Total liabilities and stockholders’ deficit 504,452 362,356
Nonrelated Party    
Current liabilities:    
Accounts payable 9,195 21,016
Related Party    
Current assets:    
Due from related parties 2,019 1,890
Current liabilities:    
Accounts payable $ 1,136 $ 3,469